Related Experiment Videos
Low-dose pulse methotrexate inhibits articular destruction of adjuvant arthritis in rats
1Institute of Medical Science, St. Marianna University School of Medicine, Kawasaki, Japan.
Abstract:
The purpose of this study was to determine whether low-dose methotrexate pulse therapy, which had recently become important in the treatment of rheumatoid arthritis, was effective for controlling the progression of articular destruction in rats with adjuvant arthritis. Intraperitoneal methotrexate at a dose of 0.05 or 0.1 mg kg-1 twice weekly inhibited inflammation in rats with adjuvant arthritis, as shown by reduction of the hind-paw volume. Methotrexate also inhibited articular destruction, as shown by X-ray findings. Although the mechanisms by which low-dose pulse methotrexate acts on rat adjuvant arthritis are still unclear, our results imply that it might effectively slow the progression of articular destruction in rheumatoid arthritis in man. In addition, assessment of articular destruction in this animal model might be useful when evaluating new treatments for rheumatoid arthritis.
Insights
Low-dose methotrexate pulse therapy effectively reduced inflammation and prevented joint destruction in rats with adjuvant arthritis. This suggests potential for treating rheumatoid arthritis progression in humans.
Area of Science:
- Immunology
- Pharmacology
- Rheumatology
Background:
- Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by joint inflammation and progressive articular destruction.
- Low-dose methotrexate (MTX) pulse therapy has emerged as a significant treatment for RA.
- The efficacy of low-dose MTX in controlling the structural damage of RA requires further investigation.
Purpose of the Study:
- To evaluate the effectiveness of low-dose methotrexate pulse therapy in inhibiting articular destruction in an adjuvant arthritis rat model.
- To assess the impact of low-dose MTX on inflammation and joint damage progression in this animal model.
Main Methods:
- Adjuvant arthritis was induced in rats.
- Rats were treated with intraperitoneal low-dose methotrexate (0.05 or 0.1 mg/kg) twice weekly.
- Inflammation was assessed by hind-paw volume measurements.
- Articular destruction was evaluated using X-ray findings.
Main Results:
- Low-dose methotrexate significantly inhibited inflammation, indicated by reduced hind-paw volume.
- Methotrexate treatment also demonstrated a significant inhibition of articular destruction, confirmed by X-ray analysis.
- The study established a dose-dependent effect of methotrexate on controlling disease progression.
Conclusions:
- Low-dose methotrexate pulse therapy is effective in controlling both inflammation and articular destruction in the adjuvant arthritis rat model.
- These findings suggest that low-dose MTX may be a valuable therapeutic strategy for slowing the progression of joint damage in human rheumatoid arthritis.
- The adjuvant arthritis model serves as a useful platform for evaluating novel treatments for rheumatoid arthritis.